DRUG
BRIGHT MINDS BIOSCIENCES INC.
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13D/A | 7/2/2026 | View on SEC |
| 6-K | 6/3/2026 | View on SEC |
| 6-K | 6/2/2026 | View on SEC |
| 6-K | 5/28/2026 | View on SEC |
| 6-K | 5/20/2026 | View on SEC |
| SCHEDULE 13G | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/12/2026 | View on SEC |
| SCHEDULE 13G/A | 4/30/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | DRUG |
| Company Name | BRIGHT MINDS BIOSCIENCES INC. |
| CIK | 1827401 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | other |
| Fiscal Year End | 0930 |
| State of Incorporation | A1 |
| Phone | 6474072515 |